Cargando…

Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy

BACKGROUND: To find prognostic biomarkers in pretreatment dynamic contrast-enhanced MRI (DCE-MRI) water-exchange-modified (WX) kinetic parameters for advanced hepatocellular carcinoma (HCC) treated with antiangiogenic monotherapy. METHODS: Twenty patients with advanced HCC underwent DCE-MRI and were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang Ho, Hayano, Koichi, Zhu, Andrew X., Sahani, Dushyant V., Yoshida, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569468/ https://www.ncbi.nlm.nih.gov/pubmed/26366997 http://dx.doi.org/10.1371/journal.pone.0136725

Ejemplares similares

Imaging for assessment of treatment response in hepatocellular carcinoma: Current update
por: Hayano, Koichi, et al.
Publicado: (2015)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion
por: Hayano, Koichi, et al.
Publicado: (2013)

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
por: Sahani, Dushyant V, et al.
Publicado: (2013)

Computer-aided detection for virtual colonoscopy
por: Perumpillichira, James J, et al.
Publicado: (2005)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
por: Zhu, Xiao-Dong, et al.
Publicado: (2011)

Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft Model
por: Song, Youngkyu, et al.
Publicado: (2013)

Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies
por: Li, Haosheng, et al.
Publicado: (2022)

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
por: Welker, Martin-Walter, et al.
Publicado: (2013)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
por: Ebos, John ML, et al.
Publicado: (2014)

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
por: Raybould, Alison L, et al.
Publicado: (2020)

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
por: Li, Ka-Loh, et al.
Publicado: (2016)

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
por: O'Connor, J P B, et al.
Publicado: (2007)

Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters
por: Kim, Cherry, et al.
Publicado: (2018)

Evaluation of Antiangiogenic Effects of a New Synthetic Candidate Drug KR-31831 on Xenografted Ovarian Carcinoma Using Dynamic Contrast Enhanced MRI
por: Yang, Jehoon, et al.
Publicado: (2011)

AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
por: Suresh, Diwakar, et al.
Publicado: (2023)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
por: Furukawa, Koichi, et al.
Publicado: (2020)

Redesigned reporter gene for improved proton exchange-based molecular MRI contrast
por: Perlman, Or, et al.
Publicado: (2020)

How to Take Good Care of Your Radiology Department Chair and Why
por: Shuman, William P., et al.
Publicado: (2023)

Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI
por: Cho, Hye Rim, et al.
Publicado: (2019)

Diffusion-Weighted MRI Is Insensitive to Changes in the Tumor Microenvironment Induced by Antiangiogenic Therapy()()
por: Hauge, Anette, et al.
Publicado: (2018)

Improved parameter-estimation with combined PET-MRI kinetic modelling
por: Erlandsson, Kjell, et al.
Publicado: (2015)

Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?
por: Wenger, Justin B., et al.
Publicado: (2011)

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact
por: Federico, Piera, et al.
Publicado: (2022)

Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
por: Woodall, Ryan T, et al.
Publicado: (2021)

Mapping of Absolute Host Concentration and Exchange Kinetics of Xenon Hyper-CEST MRI Agents
por: Kunth, Martin, et al.
Publicado: (2021)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

Antiangiogenic Effect of Alkaloids
por: Alasvand, Masoud, et al.
Publicado: (2019)

Antiangiogeneic Strategies in Mesothelioma
por: Nowak, Anna K., et al.
Publicado: (2020)

Modified Gadonanotubes as a promising novel MRI contrasting agent
por: Jahanbakhsh, Rouzbeh, et al.
Publicado: (2013)

Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI
por: Zhu, Wenlian, et al.
Publicado: (2014)

Automatic Prostate Cancer Segmentation Using Kinetic Analysis in Dynamic Contrast-Enhanced MRI
por: Navaei Lavasani, S., et al.
Publicado: (2018)

Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer
por: Wu, Shandong, et al.
Publicado: (2016)

Dual‐input tracer kinetic modeling of dynamic contrast‐enhanced MRI in thoracic malignancies
por: Lee, Sang Ho, et al.
Publicado: (2019)

Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis
por: Kim, Sung Hun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uhe2kbmots9umcajsmu8v0ju21